Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-003642
Filing Date
2010-01-19
Accepted
2010-01-19 19:36:21
Documents
2
Period of Report
2010-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4236
2 POA DOCUMENT poa.txt EX-24.4_313006 2782
  Complete submission text file 0001209191-10-003642.txt   8716
Mailing Address INDEVUS PHARMACEUTICALS, INC. 99 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Beerman Noah D (Reporting) CIK: 0001303479 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 10534500

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations